WO2007031879A3 - Méthodes permettant de réduire la gravité de la mucosite orale et gastro-intestinale - Google Patents
Méthodes permettant de réduire la gravité de la mucosite orale et gastro-intestinale Download PDFInfo
- Publication number
- WO2007031879A3 WO2007031879A3 PCT/IB2006/003538 IB2006003538W WO2007031879A3 WO 2007031879 A3 WO2007031879 A3 WO 2007031879A3 IB 2006003538 W IB2006003538 W IB 2006003538W WO 2007031879 A3 WO2007031879 A3 WO 2007031879A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- analogs
- lipid
- gastrointestinal mucositis
- treating oral
- oral
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06831669A EP1879597A2 (fr) | 2005-05-13 | 2006-05-15 | Méthodes permettant de réduire la gravité de la mucosite orale et gastro-intestinale |
AU2006290437A AU2006290437A1 (en) | 2005-05-13 | 2006-05-15 | Methods of reducing the severity of oral and gastrointestinal mucositis |
CA002606727A CA2606727A1 (fr) | 2005-05-13 | 2006-05-15 | Methodes permettant de reduire la gravite de la mucosite orale et gastro-intestinale |
JP2008510678A JP2008540510A (ja) | 2005-05-13 | 2006-05-15 | 口腔粘膜炎及び胃腸粘膜炎の症状を緩和させる方法 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68073305P | 2005-05-13 | 2005-05-13 | |
US60/680,733 | 2005-05-13 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007031879A2 WO2007031879A2 (fr) | 2007-03-22 |
WO2007031879A3 true WO2007031879A3 (fr) | 2007-10-04 |
Family
ID=37772612
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2006/003538 WO2007031879A2 (fr) | 2005-05-13 | 2006-05-15 | Méthodes permettant de réduire la gravité de la mucosite orale et gastro-intestinale |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1879597A2 (fr) |
JP (1) | JP2008540510A (fr) |
KR (1) | KR20080038085A (fr) |
CN (1) | CN101262870A (fr) |
AU (1) | AU2006290437A1 (fr) |
CA (1) | CA2606727A1 (fr) |
WO (1) | WO2007031879A2 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT2185581E (pt) * | 2007-07-06 | 2015-12-09 | Promedior Inc | Processos e composições úteis no tratamento de mucosite |
WO2009152517A1 (fr) * | 2008-06-13 | 2009-12-17 | Case Western Reserve University | Compositions et procédés pour le traitement d’une inflammation de la cornée |
WO2010127367A2 (fr) * | 2009-05-01 | 2010-11-04 | Alfagene Bioscience, Inc. | Système de cellules épithéliales intestinales primaires dérivées de cellules souches gastro-intestinales humaines et ses procédés d'utilisation |
BR112014024139A8 (pt) * | 2012-03-28 | 2018-01-16 | Univ Maryland | administração de eritoran ou sais farmaceuticamente aceitáveis do mesmo para tratar infecções de ortomixovírus |
CN107669692B (zh) * | 2017-09-07 | 2020-09-29 | 中国人民解放军第二军医大学 | Mpla在制备电离辐射致肠道损伤防治药物中的应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003013440A2 (fr) * | 2001-08-10 | 2003-02-20 | Eisai Co., Ltd. | Traitement et prevention de maladies et de conditions associees a la proteine de choc thermique |
US20030130212A1 (en) * | 1999-01-14 | 2003-07-10 | Rossignol Daniel P. | Administration of an anti-endotoxin drug by intravenous infusion |
-
2006
- 2006-05-15 CA CA002606727A patent/CA2606727A1/fr not_active Abandoned
- 2006-05-15 AU AU2006290437A patent/AU2006290437A1/en not_active Abandoned
- 2006-05-15 WO PCT/IB2006/003538 patent/WO2007031879A2/fr not_active Application Discontinuation
- 2006-05-15 JP JP2008510678A patent/JP2008540510A/ja not_active Withdrawn
- 2006-05-15 CN CNA2006800165614A patent/CN101262870A/zh active Pending
- 2006-05-15 EP EP06831669A patent/EP1879597A2/fr not_active Withdrawn
- 2006-05-15 KR KR1020077028786A patent/KR20080038085A/ko not_active Application Discontinuation
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030130212A1 (en) * | 1999-01-14 | 2003-07-10 | Rossignol Daniel P. | Administration of an anti-endotoxin drug by intravenous infusion |
US20050215517A1 (en) * | 1999-01-14 | 2005-09-29 | Rossignol Daniel P | Use of an anti-endotoxin drug in the prevention and treatment of disease |
WO2003013440A2 (fr) * | 2001-08-10 | 2003-02-20 | Eisai Co., Ltd. | Traitement et prevention de maladies et de conditions associees a la proteine de choc thermique |
WO2003105861A1 (fr) * | 2002-06-13 | 2003-12-24 | Eisai Co., Ltd. | Utilisation d'un medicament anti-endotoxinique pour le prevention et le traitement d'une affection |
Non-Patent Citations (2)
Title |
---|
FORT MADELINE M ET AL: "A synthetic TLR4 antagonist has anti-inflammatory effects in two murine models of inflammatory bowel disease", JOURNAL OF IMMUNOLOGY, vol. 174, no. 10, May 2005 (2005-05-01), pages 6416 - 6423, XP002436852, ISSN: 0022-1767 * |
SONIS S T: "A BIOLOGICAL APPROACH TO MUCOSITIS", JOURNAL OF SUPPORTIVE ONCOLOGY, BIOLINK COMMUNICATIONS,, US, vol. 2, no. 1, January 2004 (2004-01-01), pages 21 - 36, XP009053477, ISSN: 1544-6794 * |
Also Published As
Publication number | Publication date |
---|---|
CA2606727A1 (fr) | 2007-03-22 |
KR20080038085A (ko) | 2008-05-02 |
JP2008540510A (ja) | 2008-11-20 |
CN101262870A (zh) | 2008-09-10 |
WO2007031879A2 (fr) | 2007-03-22 |
EP1879597A2 (fr) | 2008-01-23 |
AU2006290437A1 (en) | 2007-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006058236A3 (fr) | Composition et methode pour traiter des affections neurologiques | |
WO2006058059A3 (fr) | Procede et composition pour administrer un antagoniste du recepteur de nmda a un sujet | |
WO2008057579A3 (fr) | Formes dosifiées et co-administration d'un agoniste opioïde et d'un antagoniste opioïde | |
WO2007019439A3 (fr) | Compositions de copolymere sequence et utilisations de ces dernieres | |
PL1830855T3 (pl) | Stałe podawane doustnie farmaceutyczne postacie dawkowane o zmodyfikowanym uwalnianiu zawierające riwaroksaban | |
WO2006138503A3 (fr) | Nouveaux schémas posologiques pour contraceptifs oraux monophasiques | |
WO2005079756A3 (fr) | Methodes et compositions de traitement de troubles psychiatriques | |
WO2009025876A8 (fr) | Formes cristallines de chlorhydrate d'erlotinib et formulations de celles-ci | |
WO2007027527A3 (fr) | Composes d'isoindole-imide et compositions renfermant ceux-ci et procedes d'utilisation de ceux-ci | |
SI1729753T1 (sl) | Uporaba antagonistov NMDA receptorjev za zdravljenje tinitusa povzročenega s kohlearno eksitotoksičnostjo | |
WO2007076260A3 (fr) | Agonistes de recepteur de farnesoide x | |
CY1112511T1 (el) | Κρυσταλλικη στερεα βαση ρασαγιλινης (rasagiline) | |
PL1740156T3 (pl) | Sposób wytwarzania zabezpieczonej przed nadużyciem, stałej postaci aplikacyjnej | |
WO2009084024A3 (fr) | Procédé pour la préparation de r-sitagliptine et de ses sels pharmaceutiquement acceptables | |
WO2008082613A3 (fr) | Conjugués polymère-fraction à activité facteur ix comprenant une liaison dégradable | |
IL185250A0 (en) | Microimplants for ocular administration | |
WO2005117872A3 (fr) | Antagonistes de snri-nmda a double action utilises pour traiter des troubles genito-urinaires | |
MX2009007763A (es) | Mousse. | |
WO2006124684A3 (fr) | Polytherapie | |
PL1846376T3 (pl) | Sposób otrzymywania 10,11-dihydro-10-hydroksy-5H-dibenzo/b,f/azepino-5-karboksyamidu | |
WO2007031879A3 (fr) | Méthodes permettant de réduire la gravité de la mucosite orale et gastro-intestinale | |
WO2008051564A3 (fr) | Formes cristallines d'hydrochlorure de palonosetron | |
WO2007075980A3 (fr) | Comprimes de lansoprazole se desintegrant oralement | |
HK1086542A1 (en) | Traction machine for elevators | |
WO2009059143A3 (fr) | Utilisation d'antagonistes du récepteur 4 de type toll (tlr4) pour le traitement ou la prévention de troubles ostéoarthritiques |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 2006290437 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref document number: 2006290437 Country of ref document: AU Date of ref document: 20060515 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2006290437 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2606727 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008510678 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200680016561.4 Country of ref document: CN |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006831669 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020077028786 Country of ref document: KR |
|
NENP | Non-entry into the national phase |
Ref country code: RU |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: RU |
|
WWP | Wipo information: published in national office |
Ref document number: 2006831669 Country of ref document: EP |